By this point, many people have reached or are approaching the 8 mg to 12 mg dose range where the clinical data shows the most dramatic results
Thus, whilst the CVOTs provide valuable and supportive evidence of a benefit of GLP-1 RAs on HF in people with type 2 diabetes, additional trials are required to fully understand the magnitude and nature of such a potential effect, including if it applies to both prevention and treatment of the condition
Enzyme Microb Technol 26:737742 Penninckx MJ (2002) An overview on glutathione in Saccharomyces versus non-conventional yeasts
Maintain seamless communication with your care team, ensuring effective and continuous treatment adjustment
GLP-1R activation can downregulate pro-inflammatory mediators and shift macrophage phenotypes toward anti-inflammatory profiles [15,16,17]
Heres the risk that should worry you most